Answer
Omeprazole, a CYP1A2 inducer, could decrease anagrelide exposure; effects on safety and efficacy are not established, so clinical and biological monitoring is recommended during concomitant use, with anagrelide dose adjustment if needed.
Sources for this answer
- Anagrelide Zentiva 0.5 mg hard capsulesZentiva · emc · SmPC §4.5 Interaction with other medicinal products · Version 7Document updated
Sources checked